British Columbia has long been considered the cannabis capital of Canada, but new numbers from Statistics Canada show that reputation is in jeopardy, at least when it comes to retail sales.
Recreational cannabis use is illegal in the majority of US states, but the relaxation of hemp and CBD sales has created a set of companies that could more easily grab cannabis product market share if it is legalized.
NYSE-traded cannabis company Aphria Inc. (NYSE: APHA) (TSX:APHA) and ParcelPal Technology Inc. (CSE: PKG) (OTC: PTNYF) will be announcing later today a strategic partnership for the delivery of the former’s medical cannabis products.
Tilray, Inc. (NASDAQ:TLRY), a global pioneer in cannabis research, cultivation, production and distribution, today announced it has entered into an agreement with Cannamedical Pharma GmbH (“Cannamedical”) through its wholly-owned subsidiary Tilray Portugal Unipessoal Lda.